Assignee
LEMONEX INC
KR·13 granted patents·9 pending applications·11 citations·filing 2015–2024
Top patents by PatentIndex Score
22 records- 0190US11129796B2Physiologically active substance carrierLEMONEX INC·Filed 2018·Granted Sep 28, 2021·5 cites·22 claims
- 0287US2025032414A1Physiologically active substance carrierLEMONEX INC·Filed 2024·Application pending·0 cites
- 0384US12138346B2Physiologically active substance carrierLEMONEX INC·Filed 2023·Granted Nov 12, 2024·0 cites·20 claims
- 0480US12295967B2Pharmaceutical composition for prevention or treatment of flavivirus infectionLEMONEX INC·Filed 2019·Granted May 13, 2025·2 cites·15 claims
- 0578US10809196B2Quencher containing water soluble polymer-conjugated nanomaterial and use thereofLEMONEX INC·Filed 2016·Granted Oct 20, 2020·2 cites·20 claims
- 0677US11530132B2Composition comprising porous silica particles carrying a cell fate modulating factorLEMONEX INC·Filed 2018·Granted Dec 20, 2022·2 cites·11 claims
- 0775US11793757B2Physiologically active substance carrierLEMONEX INC·Filed 2021·Granted Oct 24, 2023·0 cites·11 claims
- 0868US2023346821A1Rna and nucleic acid carrier including the sameLEMONEX INC·Filed 2023·Application pending·0 cites
- 0967US11701378B2RNA and nucleic acid carrier including the sameLEMONEX INC·Filed 2021·Granted Jul 18, 2023·0 cites·16 claims
- 1066US12076336B2Pharmaceutical composition for preventing or treating liver cancerLEMONEX INC·Filed 2021·Granted Sep 3, 2024·0 cites·9 claims
- 1162US11633447B2Pharmaceutical composition and functional health food for preventing or treating macular degenerationLEMONEX INC·Filed 2019·Granted Apr 25, 2023·0 cites·9 claims
- 1257US11779582B2Composition for preventing or treating metastatic ovarian cancer, endometrial cancer or breast cancerLEMONEX INC·Filed 2018·Granted Oct 10, 2023·0 cites·17 claims
- 1354US2024261390A1Vaccine for prevention or treatment of viral infectionLEMONEX INC·Filed 2022·Application pending·0 cites
- 1453US2021093654A1Pharmaceutical composition for preventing or treating liver cancerLEMONEX INC·Filed 2018·Application pending·0 cites
- 1553US2022040217A1Pharmaceutical composition for immune activity or for preventing or treating cancerLEMONEX INC·Filed 2021·Application pending·0 cites
- 1651US12234458B2Composition for inhibiting CTGF expressionLEMONEX INC·Filed 2021·Granted Feb 25, 2025·0 cites·10 claims
- 1745US2022280602A1Anticancer agent and method for preparation of porous silica particleLEMONEX INC·Filed 2020·Application pending·0 cites
- 1845US2020163885A1Composition for delivering physiologically active ingredients into blood vesselLEMONEX INC·Filed 2018·Application pending·0 cites
- 1944US2022110964A1Pharmaceutical composition for preventing or treating atopic diseasesLEMONEX INC·Filed 2019·Application pending·0 cites
- 2044US2021309763A1Polypeptide delivery compositionLEMONEX INC·Filed 2019·Application pending·0 cites
- 2142US12343406B2Immunoreactant carrierLEMONEX INC·Filed 2019·Granted Jul 1, 2025·0 cites·14 claims
- 2238US11786469B2Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasomeLEMONEX INC·Filed 2015·Granted Oct 17, 2023·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when LEMONEX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →